The EU is pushing back against a 28-point plan to end the war in Ukraine reportedly being drafted behind closed doors by the US and Russia, demanding that any diplomatic attempt must have Kyiv and European leaders at the table.
The plan, first reported by US outlet Axios, is said to include…
Medicines for Europe says study highlights the need for reforms to secure patient access to medicines.
Medicines for Europe says that a recent study by New Angle highlights the need for reforms to national pricing and procurement systems to secure patient access to medicines.
The study,…
By Euronews
Published on
Kosovo parliament on Wednesday failed to elect a new government in a last-ditch attempt, paving the way for a snap election following…
How a single oversight before your move abroad can drain your savings, and the simple step to avoid it, writes Expat Tax Thailand, www.expattaxthailand.com.
Key points:
IRU welcomes the European Commission and High Representative’s new Military Mobility Package and calls for practical civil and military cooperation to keep the EU’s transport network strong and ready. The package, comprising a new regulation and a strategic joint communication, recognizes…
Poain registration surges with investors after non-volatility income instruments
The International Monetary Fund (IMF) has published a new commentary that noted increasing vulnerabilities of global financial markets, citing increased liquidity stress and high volatility of digital…
The European Citizens’ Panel on Intergenerational Fairness has agreed on a final set of recommendations to the European Commission that will shape the first EU Strategy on Intergenerational Fairness.
The final recommendations encourage fair and responsible policy making that focuses on the…
Ethiopia’s Ministry of TourismTwelve historical artefacts have been formally returned to Ethiopia after being kept by a German family for more than 100 years.
The artefacts, originally…
The Commission has granted EU marketing authorization for ‘brensocatib’, a new active substance for the treatment of chronic progressive lung disease (non-cystic fibrosis bronchiectasis, or NCFB) in patients aged 12 years and older. The estimated number of patients with NCFB in the EU ranges…
Updated: